chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approxamately 10 to 12 hours after receiving 2nd Moderna Covid 19 vaccine, I awoke to breathing problems.  I felt outof breath, and was breathing very heavy and labored for about 6 hours.   I considered calling 911 but although I was breathing heavily and out of breath, I did not get any worse, I was able to breathe well enough to keep from panicing, never called 911 and recovered on my own.   Then  it quickly went away after about 6 hours  and I was breathing normally.   I went back to sleep.  I have severe COPD, not on Oxygen yet.  I only had a slight tiredness after the first dose, as did my wife .  She had no reaction at all to second shot.  She does not have any health problems.
This spontaneous report was received from a pharmacist, concerning a 32 year old male patient. The patient's medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 23-SEP-2017, the patient was vaccinated with the first dose of Human Papillomavirus GARDASIL 9 (strength, lot #, expiration date, dose, route of administration, and anatomical location were not reported), for prophylaxis. On 26-OCT-2017, the patient entered the pharmacy and requested the second dose of his GARDASIL 9 vaccination series; which was considered as an inappropriate schedule of vaccine administered. No adverse effects were reported. No product quality complaint (PQC) was involved.
vomiting, diarrhea & malaise are reported in a pt who recvd flu vax; above sx occurred w/in 24-48 hrs of vax; pt has recovered from above sx;
Itching all over, here and there; red spots on chest; rash at injection site with itching; rash at injection site; Feverish feeling; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching all over, here and there), RASH MACULAR (red spots on chest), VACCINATION SITE PRURITUS (rash at injection site with itching), VACCINATION SITE RASH (rash at injection site) and PYREXIA (Feverish feeling) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A and 003C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching all over, here and there), RASH MACULAR (red spots on chest), VACCINATION SITE PRURITUS (rash at injection site with itching), VACCINATION SITE RASH (rash at injection site) and PYREXIA (Feverish feeling). At the time of the report, PRURITUS (Itching all over, here and there), RASH MACULAR (red spots on chest), VACCINATION SITE PRURITUS (rash at injection site with itching), VACCINATION SITE RASH (rash at injection site) and PYREXIA (Feverish feeling) outcome was unknown.            No concomitant medications were reported, No  treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jun-2021: Additional information received captured product details and event.
Patient was given 0.2ML of the 30MCG formulation instead of 0.2ML of the 10MCG formula.
After day 9, severe nausea and vertigo. Lasted 7 days decreasing in severity.
This spontaneous report as received from a pharmacist refers to a newborn female patient of unknown age. On 31-OCT-2012 13:03, the patient was vaccinated with RECOMBIVAX HB that had been exposed to temperatures below 32F for 6 hours. During that 6 hour time period, the vaccine was exposed to 28.8F for 1.5 hours. Administration route was not reported. Two lot# were involved and the lot# were reported as: 0294AE, expiry date on 06-SEP-2014; and 0385AE, expiry date on 08-NOV-2014. It was unspecified which lot# the patient was administered. The outcome of event was unknown. It was unspecified if the patient sought medical attention. This is one of several reports received from the same source. Additional information has been requested.
PAINFUL KNOT ON PREVIOUS VERICOSE VEINS ON LEFT LEG (KNOT WAS SORE TO THE TOUCH); This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included varicose vein. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 23-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 08-APR-2021, the subject experienced painful knot on previous vericose veins on left leg (knot was sore to the touch). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from painful knot on previous vericose veins on left leg (knot was sore to the touch). This report was non-serious.
immediately p/receiving MMR vax pt became very sluggish & unresponsive taken to urgent care immediate facility on 2OCT92; pt back to work on 5OCT92;
Assumed from Shingrix. Severe searing, superficial pain on back, left side only, immediately lateral to spine  approximately T-5 or T6. Intermittent, no rash or redness.
Case number PHEH2012US014300 is an initial spontaneous report received from a medical assistant on 13 Jul 2012: This report refers to a patient of unknown age group and gender. This patient was given only the CYW-135 liquid component of MENVEO vaccine (batch number: unknown) intramuscularly on an undetermined date. The reporter stated that they had an extra vial which caused them to realize their mistake. No other adverse reaction was reported following this administration error.
Approximately 20 minutes following COVID-19 vaccination the patient suddenly developed hives, itching - Hives around face and upper chest. Throat was red and slightly swollen. Was brought to the Emergency Department within out hospital for assessment and medical care.  Acute treatment included methylprednisolone 125 mg IV x 1 dose, diphenhydramine 50 mg IV x 1 dose, epinephrine 0.3 mg IM x 1 dose, and famotidine 20 mg IV x 1 dose. The patient felt better following this treatment  Upon reassessment oropharyngeal swelling had improved, the patient no longer had hives and the throat appeared clear. The patient stated he no longer feels itchy but does feel a little short of breath. Lungs were clear with  pulse oximetry 97%.
Got shot at 8:30 am on 8/3/2020 First side effect ay 6:30 pm fever 101.7 then at 10 pm additional side affects headache,  stomach ache and small hive on my right wrist.  On 8/4/2020 at 2:30 am my body began to shiver for about 15 minutes and muscle pain, my temperature was 101.5 Wife gave me one tablet of Tylenol 500 mg . At 6:00 am my temperature subsides to 99.8 At 12:00 pm my temperature subsides again to 98.9 without side affects. At 8pm took a second dose of 1000 mg of Tylenol with temperature at 99.7 On 8/5/20 @ 10 am woke up without any side affects and my body temperature returned to normal 97.8
5 minutes after administration of vaccine, patient reported left sided chest discomfort rated at 3/10. No other associated symptoms. Pain resolved after 20 minutes without intervention. Normal vitals, EKG, and examination completed. Patient discharged home with strict ER precautions.
I could barely walk on my feet due to the swelling and my hand were also swollen; I could barely walk on my feet due to the swelling and my hand were also swollen; 'pink palm' started to itch and swell; Woke in the morning with a rash and itch on the right foot between the toes; Woke in the morning with a rash and itch on the right foot between the toes; This is a spontaneous report from a contactable consumer (patient). A 77-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number was not reported), via an unspecified route of administration on 04Mar2021 13:14 at the age of 77-year-old as dose 1, single for covid-19 immunisation. Medical history included blood pressure. Concomitant medications included irbesartan, levothyroxine sodium, acetylsalicylic acid (BABY ASPIRIN), calcium and fish oil all taken for an unspecified indication, start and stop date were not reported. On 05Mar2021, patient woke in the morning with a rash and itch on the right foot between the toes. On 06Mar2021 woke to a rash and itch on the left foot between the toes, right foot has now a rash on top of foot. On 07Mar2021 she woke in the morning in right foot both rash and itching on toes, on top of toes, ankles and arch. A rash and itching around ankle, tried the medication the calamine lotion (treatment). On 09Mar2021 she woke with the bottom of the foot starting to swell, she noted rash starting on the top of the thumb, joint and took aleve and benadryl (treatment) to sleep, then on 10Mar2021 the 'pink palm' started to itch and swell. Patient called the primary care physician he told that he is unable to see on the Thursday or Friday that was the reaction due to COVID Vaccine, he told me to get an appointment to dermatologist within 3 to 4 weeks if the symptoms continue then patient  reach out the emergency care center, next days she called the urgent care and  got a five days prescription for Prednisone 20 mg (treatment) and that night she felt a lot better. Patient tried things but nothing worked like 'Cortizone-10' (not clarified, hence suspect captured as Unspecified Medication) and she tried resting. Then, on Saturday patient could barely walk on feet due to the swelling and hand were also swollen, no fever or pain just swelling rash and itching, examined by a nurse practitioner stated that she is unable to determine the cause of the reaction. By 6 o'clock that evening she could feel the relieve from itching and swelling. Patient still have the rash going on. The patient was going to get a second injection next day. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected
This spontaneous report was received from an unspecified reporter referring to an unknown number of patients of unknown age and gender. The patients' pertinent medical history, concurrent conditions and concomitant medications were not provided. On an unspecified date in 2018, the patients were vaccinated with incorrect stored PNEUMOVAX23 lot # N027624, expiration date on 11-MAY-2019 and M-M-R II lot #N020925, expiration date on 01-AUG-2019; both for prophylaxis. The vaccine's strengths, doses, routes of administration and anatomical locations were not reported. Both vaccines were incorrectly stored between 18-JAN-2018 and 30-JAN-2018. The temperature at they were stored was between 34.00°F and 34.90°F during 0.17 hours.
This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Arm  soreness), INJECTION SITE REACTION (Delayed injection site reaction), INJECTION SITE BRUISING (Bruise at injection site), VACCINATION SITE PRURITUS (Injection site itching) and VACCINATION SITE URTICARIA (Injection site hives) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm  soreness). On 03-Jan-2021, the patient experienced INJECTION SITE REACTION (Delayed injection site reaction), INJECTION SITE BRUISING (Bruise at injection site), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE URTICARIA (Injection site hives), VACCINATION SITE INDURATION (Injection site induration) and VACCINATION SITE ERYTHEMA (Injection site redness). On 26-Dec-2020, PAIN IN EXTREMITY (Arm  soreness) had resolved. At the time of the report, INJECTION SITE REACTION (Delayed injection site reaction), INJECTION SITE BRUISING (Bruise at injection site), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE URTICARIA (Injection site hives), VACCINATION SITE INDURATION (Injection site induration) and VACCINATION SITE ERYTHEMA (Injection site redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. Patient was instructed to use Benadryl cream or over the counter anti-histamine to treat the events.
2nd dose of Shingrix vaccine 5 weeks after she received the first dose; This case was reported by a other health professional and described the occurrence of drug dose administration interval too short in a 66-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The healh care professional reported that a female patient, 66 years old received the 2nd dose of Shingrix vaccine 5 weeks after she received the first dose, which led to shortening of vaccination schedule. The reporter consented to follow up.
Patient reports feeling heavy on her left leg, feeling unwell/nauseous.  No shortness of breath reported.  Patient took amlodipine just prior to appointment. 0941 BP = 169/84; 0948 BP = 188/86 and HR = 77. Patient feels dizzy with a slight headache, but nausea has decreased. 0955  L Arm BP = 194/93, HR = 79, dizziness and nausea decreased.  Patient states she didn't take omeprazole this am.  1010  BP = 187/90, HR = 78, RR = 22, O2 Sat = 100%. Patient states she is to take a clonidine for elevated BP.  Patient released to home and advised to check BP there and take clonidine as ordered by primary MD and will take her other medications as well.
Severe nausea and vomiting along with chills , fever, body aches and headache.  Could not keep anything down including Tylenol.  This took place from 11pm  until 10 am this morning.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. On 11-NOV-2014, the patients were vaccinated with doses of VARIVAX (Merck) (lot # J012377 exp date 03-OCT-2015 also reported as 08-NOV-2014) (dose not reported) subcutaneously that were improperly exposed to 7 degrees C from 13-MAY-2014 to 11-NOV-2014. No known adverse effects were reported. This is one of several reports received from the same source. Additional information is not expected. All follow ups requested to complete the case were received.
Moderna COVID 19 Vaccine EUA PATIENT WAS GIVEN THE VACCINE PASSED 30 DAYS AFTER THAWED.  NO NEGATIVE REACTIONS NOTED
Mild Itching at injection site .  Today 3/20/2021, 8 days after the shot) the itching has gotten slightly more and there is redness and swelling at the injection site. The red patch area and swelling is about  2? diameter.
After being vaccinated, the patient wasn't able to stand and hold her own weight. It seemed like her leg muscles were weak.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 25-NOV-2015, the patient was vaccinated with 3rd dose of improperly stored GARDASIL with lot number: K011562, expiry date: 08-APR-2017 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
Pt developed seizure activity-8/29/01 lasting 30-60 sec. at R sided rhythmic arm, leg and face jerking. Had generalized seizure 9/1/01 lasting 1 1/2 min, pt airlfted to hospital. CT, LP, CBC and MRI normal. VSS x mild fe 38 degrees. Pt noted to have poor truncal tone and hypertonic arms and legs. Tx with Phenobarb and Topimax. EEG 9/11/01-abnormal activity L side of brain. Follow up states pt did not recover. Intractable seizures.  Follow up on 12/08/03: "Vaccine recepient has not recovered from the adverse events that were reported for this vaccination.  Still has intractable seizures approximately every 3 days, shows some improvement on ketogenic diet. has mitral condrial defect, has polymicrogyria."
11:00 am spoke with mom said pt got FLUMIST on 9-16-09. Pt has been c/o stomach pain, ache arms, headache, runny nose no fever no diarrhea. Mom's concern pt has flu? some symptoms. Mom would also like to know if its due to the "FLUMIST". 9/16/09 - Notify parent. It could be a minor reaction. Since the vaccine is a live, weakened virus - it can cause minor symptoms resembling the flu, not the actual flu. If questions remain - I can answer questions. Please initiate VAERS report. 12:00 p.m. spoke with mom inform her it could be a minor reaction from FLUMIST per Dr. Inform mom, if pt's symptoms worsen or Pt gets fever to call us back to schedule app. Mom verbally understood and agree.
After about 10 minutes after the vaccine administration the patient notified us of some kind of 'ear swelling' sensation and/or 'pressure' in the ears. Told patient it could potentially be due to the vaccine, it is not a common reaction, and told to go seek medical attention (urgent care). Patient agreed.
Patient had Tdap and Covid booster on 12/12/22. He noted facial pain, jaw pain and headache starting 12/15/22. I suspect trigeminal neuralgia.
Patient reported having pain and fever which began the evening after receiving the vaccination. The pain lasted for about 5 days and the fever lasted for 2 days. The patient also reported having red blotches on her left arm only five days after receiving the vaccination. The pain and fever were resolved taking ibuprofen and the blotches are clearing up on their own.
2nd dose not administered yet; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2018).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. The patient did not receive the 2nd dose till the time of reporting, which led to incomplete course of vaccination. No further information reported. The reporter consented to follow-up. This case has been linked with case US2021251176, reported by the same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021251176:Same reporter
Fatigue, SEVERE joint pain, muscle aches and mild headache and nausea.  Was up crying during the night (Sunday night - day of injection) with joint pain and had difficulty walking.  Took a sick day at work on Monday - laid in bed all day Monday only getting up to eat once and go to the restroom. Symptoms were improved on Tuesday but remained.  Wednesday, again improved but mildly lingering.
I received the Covid booster (Moderna) on 11/4/2021 on my left arm.  Prior to that I finished the two vaccines for moderna with date of last vaccine 2/13/2021. After the booster, my left arm was starting off to hurt which was expected . I went to sleep and the next day woke up with worsened left arm pain around injection site but also my left armpit was hurting underneath. Over the course of the day, the pain worsened and when I showered at night, I noticed it felt swollen and like a lump. My physician stated that it?s likely a swollen lymph node as a result of the vaccine.
Pt recvd vax 8OCT93 & the next day was found in apartment in unresponsive state; adm to hosp w/fatigue & resp depression & intubated; on PE pt was febrile to 102 & generalized weakness; lab exam revealed elevated WBC count; LP nl, & CT
injection site pain; injection site swelling; redness at injection site; waking several hours; vomiting; participate in any meaningful activity for 2 full days / not quite up to my normal activities; anorexia; weakness; general fatigue / feeling very tired; nausea; bloting; abdominal pain; headache; muscle pain; chills; This case was reported by a consumer and described the occurrence of injection site pain in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th June 2019, the patient received the 1st dose of Shingrix (intramuscular). On 7th June 2019, less than a day after receiving Shingrix, the patient experienced injection site pain, injection site swelling and injection site erythema. In June 2019, the patient experienced hypersomnia, headache, muscle pain, chills, nausea, bloating, abdominal pain, vomiting, activities of daily living impaired, anorexia, weakness and fatigue. The patient was treated with paracetamol (Acetaminophen). On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema, hypersomnia, vomiting, activities of daily living impaired, anorexia, weakness and fatigue were unknown and the outcome of the headache, muscle pain, chills, nausea, bloating and abdominal pain were recovered/resolved.   The reporter considered the injection site pain, injection site swelling, injection site erythema, hypersomnia, headache, muscle pain, chills, nausea, bloating, abdominal pain, vomiting, activities of daily living impaired, anorexia, weakness and fatigue to be related to Shingrix.  Additional details were provided as follows: The patient received 1st dose of Shingrix on an unknown deltoid. 3 to 4 hours after vaccination, the patient expereinced pain, swelling and redness at injection site. The patient had anticipated the events. The patient also took several hours more to wake up with severe headache, muscle pain, chills, nausea, bloating and abdominal pain. The patient also expereinced vomiting. The patient was tired, experienced anorexia, weakness and was not able to participate in any meaningful activity for 2 full days. The patient stated that she will not take 2nd dose and would would rather take chances of getting shingles rather than feel as bad as she have felt for the past 3-4 days.
I was having some nausea and just didn't feel right. I was achy and was just feeling poorly. I took a COVID-19 Home Test and it was negative. The next day I was still feeling poorly and I tested again and it was positive. I called my Doctor but could not get in that day and I called an urgent and they sent a test out to me and it was also positive. My this point I was having a sore throat, fever, achiness, congestion, and a cough. My Doctor gave me Paxlovid and that was also when I was starting to get better. At this point I have recovered but I still have a small lingering cough.